Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

MetLife (MET) Stock Forecast & Price Target

MetLife logo
$98.86 -4.71 (-4.55%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$98.89 +0.03 (+0.03%)
As of 10/23/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MetLife - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
2
Buy
13

Based on 15 Wall Street analysts who have issued ratings for MetLife in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 2 have given a hold rating, and 13 have given a buy rating for MET.

Consensus Price Target

$105.44
6.65% Upside
According to the 15 analysts' twelve-month price targets for MetLife, the average price target is $105.44. The highest price target for MET is $115.00, while the lowest price target for MET is $80.00. The average price target represents a forecasted upside of 6.65% from the current price of $98.86.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for MET and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for MetLife and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MET Analyst Ratings Over Time

TypeCurrent Forecast
10/25/25 to 10/25/26
1 Month Ago
9/25/25 to 9/25/26
3 Months Ago
7/27/25 to 7/27/26
1 Year Ago
10/25/24 to 10/25/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
13 Buy rating(s)
13 Buy rating(s)
12 Buy rating(s)
9 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$105.44$103.06$99.00$95.18
Forecasted Upside6.65% Upside5.33% Upside3.98% Upside20.93% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

MET Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MET Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

MetLife Stock vs. The Competition

TypeMetLifeFinance CompaniesBroader Market
Consensus Rating Score
2.87
2.28
2.53
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside6.65% Upside37.84% Upside16.92% Upside
News Sentiment Rating
Positive News

See Recent MET News
Positive News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/21/2026
TD Cowen logo
TD Cowen
3 of 5 stars
Boost TargetBuy$110.00 ➝ $114.00+11.69%
10/15/2026
Pablo Singzon
Pablo Singzon
Not Rated
Boost TargetOverweight$108.00 ➝ $110.00+11.30%
10/12/2026Boost TargetOverweight$109.00 ➝ $110.00+10.59%
10/7/2026Lower TargetOutperform$112.00 ➝ $109.00+13.45%
10/7/2026Boost TargetOverweight$97.00 ➝ $111.00+14.17%
10/6/2026Boost TargetBuy$105.00 ➝ $110.00+13.44%
9/22/2026UpgradeNeutral ➝ Overweight$99.00 ➝ $110.00+13.71%
9/11/2026 Reiterated RatingBuy (B)
9/2/2026 Boost TargetBuy$93.00 ➝ $109.00+9.16%
8/24/2026 Reiterated RatingMixed
8/24/2026Boost TargetOverweight$103.00 ➝ $111.00+16.15%
8/11/2026Boost TargetOutperform$105.00 ➝ $108.00+11.39%
8/10/2026Boost TargetBuy$103.00 ➝ $115.00+15.17%
7/15/2026 Set Target$103.00+11.65%
7/15/2026Lower TargetBuy$106.00 ➝ $103.00+3.15%
5/15/2026 Boost TargetMarket Perform$78.00 ➝ $80.00-19.88%
2/6/2026 Lower TargetOutperform$91.00 ➝ $89.00-10.87%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 02:49 PM ET.


Should I Buy MetLife Stock? MET Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 23, 2026. Please send any questions or comments about these MetLife pros and cons to contact@marketbeat.com.

MetLife
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in MetLife, Inc.:

  • MetLife, Inc. recently beat its earnings expectations, reporting $2.43 in earnings per share for the quarter compared to the consensus estimate of $2.30, which demonstrates the company's ability to outperform analyst forecasts and generate strong profitability with a return on equity of 23.39%.
  • The company has a strong consensus rating of Moderate Buy from thirteen analysts who have assigned a Buy rating, with a consensus price target of $105.44 that suggests potential upside from the current stock price of $98.86.
  • MetLife, Inc. recently authorized a $3.00 billion share buyback plan, which allows the company to repurchase up to 4.8% of its stock, a move that often signals management believes the shares are undervalued and can support the stock price.
  • Institutional investors are showing increased confidence in the stock, with Cantor Fitzgerald Investment Advisors L.P. increasing its holdings by 19.5% in the third quarter and Robeco Institutional Asset Management B.V. boosting its position by 159.3% during the same period.
  • The stock offers a dividend yield of 2.32% with a payout ratio of 45.40%, providing a steady income stream for investors while maintaining a sustainable level of cash flow for the company's operations.

MetLife
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in MetLife, Inc. for these reasons:

  • MetLife, Inc. shares dropped 4.71% to a current price of $98.86, losing the $100 level in a single session, which indicates short-term selling pressure and potential volatility ahead of the upcoming third-quarter earnings release.
  • The company's current ratio and quick ratio are both at 0.20, which is significantly low and suggests that MetLife, Inc. may have limited liquid assets to cover its short-term liabilities, potentially posing a liquidity risk.
  • Some analysts have recently lowered their price targets, such as Mizuho dropping its target from $112.00 to $109.00, reflecting a cautious outlook on the stock's valuation and future growth potential.
  • MetLife, Inc. has a debt-to-equity ratio of 0.52, indicating a moderate level of leverage that could become a burden if interest rates rise or if the company's earnings decline, affecting its financial flexibility.
  • The stock's performance has been mixed, with the 50-day moving average at $97.12 and the 200-day moving average at $89.52, suggesting that while the stock has been trending up, it may be approaching a resistance level that could limit further gains.

MET Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for MetLife is $105.44, with a high forecast of $115.00 and a low forecast of $80.00.

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MetLife in the last twelve months. There are currently 2 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MET shares.

According to analysts, MetLife's stock has a predicted upside of 6.65% based on their 12-month stock forecasts.

Over the previous 90 days, MetLife's stock had 1 upgrade by analysts.

Analysts like MetLife more than other "finance" companies. The consensus rating for MetLife is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how MET compares to other companies.


MarketBeat monitors more than a dozen sources for MetLife analyst ratings, with the most recent rating issued on 10/21/2026.
From Our Partners